Boeing Paid $4.7 Billion to Buy Back a Business It Sold in 2005

Boeing agreed to sell Wisk Aero, Insitu, and SkyGrid to Archer Aviation (closing expected by end-2026 pending antitrust review), while keeping a stake and technology-access rights for autonomous-flight know-how. The article frames this as capital reallocation after Boeing’s Dec. 8, 2025 close of a $4.7B Spirit reacquisition (about $8.3B including assumed debt) and cites improving fundamentals: Q2 revenue rose 8% YoY to $24.6B, free cash flow swung to +$631M (from -$200M a year ago), and adjusted EPS loss narrowed to -$0.76 from -$1.24. With a record $715B backlog but constrained production capacity and a $45.9B debt balance, the news is supportive but not fully de-risking for the equity recovery.

Analysis

Boeing is signaling that the highest-return use of capital is now balance-sheet repair and control of the commercial assembly line, not preserving every adjacent venture. That matters because the equity is still trading like a turnaround with execution risk: if management can keep converting backlog into deliveries and cash while trimming non-core assets, the market should start pricing BA off forward free cash flow rather than legacy liabilities. The divestitures themselves are small versus the debt load, but they improve optionality by reducing organizational sprawl and funding the parts of the business that actually move earnings.

For ACHR, the strategic benefit is real but mostly intangible near term. Access to Boeing technology may improve credibility with regulators, OEMs, and defense customers, yet it does not shorten the hard gates that matter over the next 12-24 months: certification, manufacturing scale, and financing. The bigger second-order effect is that Boeing is effectively choosing to keep the core aircraft economics inside the fence while outsourcing long-dated autonomy exposure; that lowers the immediate value of the deal to Archer unless eVTOL adoption accelerates faster than the market expects.

The contrarian read is that the market may be overweighting the symbolic transfer of future-flight assets and underweighting how little revenue or cash flow that changes today. For BA, the risk is that investors celebrate capital discipline before it is proven: one quality setback or another quarter of negative free cash flow would quickly turn this from a rerating story into another balance-sheet repair narrative. For ACHR, the thesis breaks if the deal becomes a slow antitrust process with no visible certification or funding milestone; at that point, the acquisition is just optionality that may not be monetized for years.

Key Decisions for Investors

• Long BA for 1-3 months on pullbacks: express the view that the market will increasingly reward free-cash-flow repair and backlog conversion. Upside is a multiple rerating if deliveries and FCF stay positive; invalidate on any renewed quality-driven delivery slip or a return to negative quarterly FCF.
• Pair trade: long BA / short ACHR into strength over the next 2-6 weeks. This is a cash-flow recovery vs. long-dated option-value expression; it works if investors overpay for Archer’s strategic narrative. Cover if ACHR shows concrete certification progress or if BA stumbles on execution.
• Treat ACHR as a watch item, not a core long, unless you can underwrite a 12-24 month autonomy timeline: the deal is more about strategic legitimacy than near-term earnings. If buying, use only as a small speculative position with a hard stop on any delay in antitrust review or financing stress.